Comparing the clinical effectiveness of different new-born hearing screening strategies. A decision analysis

<p>Abstract</p> <p>Background</p> <p>Children with congenital hearing impairment benefit from early detection and treatment. At present, no model exists which explicitly quantifies the effectiveness of universal newborn hearing screening (UNHS) versus other programme al...

詳細記述

保存先:
書誌詳細
主要な著者: Schnell-Inderst Petra (著者), Siebert Uwe (著者), Hessel Franz (著者), Grill Eva (著者), Kunze Silke (著者), Nickisch Andreas (著者), Wasem Jürgen (著者)
フォーマット: 図書
出版事項: BMC, 2005-01-01T00:00:00Z.
主題:
オンライン・アクセス:Connect to this object online.
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_c4e1d44af92c4462be7ea0209b875dc1
042 |a dc 
100 1 0 |a Schnell-Inderst Petra  |e author 
700 1 0 |a Siebert Uwe  |e author 
700 1 0 |a Hessel Franz  |e author 
700 1 0 |a Grill Eva  |e author 
700 1 0 |a Kunze Silke  |e author 
700 1 0 |a Nickisch Andreas  |e author 
700 1 0 |a Wasem Jürgen  |e author 
245 0 0 |a Comparing the clinical effectiveness of different new-born hearing screening strategies. A decision analysis 
260 |b BMC,   |c 2005-01-01T00:00:00Z. 
500 |a 10.1186/1471-2458-5-12 
500 |a 1471-2458 
520 |a <p>Abstract</p> <p>Background</p> <p>Children with congenital hearing impairment benefit from early detection and treatment. At present, no model exists which explicitly quantifies the effectiveness of universal newborn hearing screening (UNHS) versus other programme alternatives in terms of early diagnosis. It has yet to be considered whether early diagnosis (within the first few months) of hearing impairment is of importance with regard to the further development of the child compared with effects resulting from a later diagnosis. The objective was to systematically compare two screening strategies for the early detection of new-born hearing disorders, UNHS and risk factor screening, with no systematic screening regarding their influence on early diagnosis.</p> <p>Methods</p> <p><b>Design: </b>Clinical effectiveness analysis using a Markov Model.</p> <p><b>Data Sources: </b>Systematic literature review, empirical data survey, and expert opinion. <b>Target Population: </b>All newborn babies.</p> <p><b>Time scale: </b>6, 12 and 120 months.</p> <p><b>Perspective: </b>Health care system.</p> <p><b>Compared Strategies: </b>UNHS, Risk factor screening (RS), no systematic screening (NS). <b>Outcome Measures: </b>Quality weighted detected child months (QCM).</p> <p>Results</p> <p>UNHS detected 644 QCM up until the age of 6 months (72,2%). RS detected 393 child months (44,1%) and no systematic screening 152 child months (17,0%). UNHS detected 74,3% and 86,7% weighted child months at 12 and 120 months, RS 48,4% and 73,3%, NS 23,7% and 60,6%. At the age of 6 months UNHS identified approximately 75% of all children born with hearing impairment, RS 50% and NS 25%. At the time of screening UNHS marked 10% of screened healthy children for further testing (false positives), RS 2%. UNHS demonstrated higher effectiveness even under a wide range of relevant parameters. The model was insensitive to test parameters within the assumed range but results varied along the prevalence of hearing impairment.</p> <p>Conclusion</p> <p>We have shown that UNHS is able to detect hearing impairment at an earlier age and more accurately than selective RS. Further research should be carried out to establish the effects of hearing loss on the quality of life of an individual, its influence on school performance and career achievement and the differences made by early fitting of a hearing aid on these factors.</p> 
546 |a EN 
690 |a Public aspects of medicine 
690 |a RA1-1270 
655 7 |a article  |2 local 
786 0 |n BMC Public Health, Vol 5, Iss 1, p 12 (2005) 
787 0 |n http://www.biomedcentral.com/1471-2458/5/12 
787 0 |n https://doaj.org/toc/1471-2458 
856 4 1 |u https://doaj.org/article/c4e1d44af92c4462be7ea0209b875dc1  |z Connect to this object online.